论文部分内容阅读
目的探讨空腹血糖联合糖化血红蛋白检测筛查对糖尿病的临床应用价值。方法选择2012年6月至2014年6月糖尿病筛查的特定人群350例作为研究对象,分别对其进行空腹血糖以及糖化血红蛋白检测,以筛选出糖尿病风险患者。结果 350例患者检测出空腹血糖水平≥7.0 mmol/L者共有47例,占全部筛查人群的13.43%;检测出糖化血红蛋白水平≥6.5%者共有44例,占全部筛查人群的12.57%;检测出空腹血糖含量≥7.0 mmol/L和糖化血红蛋白含量≥6.5%者共68例,占全部筛查人群的19.43%;空腹血糖单项测定结果与糖化血红蛋白单项测定结果相比,差异未见统计学意义(P>0.05);联合测定结果与两个单项测定结果相比,差异均有统计学意义(χ2=4.5886,6.1225,P<0.05)。结论采用空腹血糖联合糖化血红蛋白检测筛查糖尿病,可以有效提高糖尿病患者的筛查率,为糖尿病的早期诊断与治疗提供有力依据,值得推广使用。
Objective To investigate the clinical value of fasting blood glucose combined with glycosylated hemoglobin test in the diagnosis of diabetes. Methods A total of 350 diabetic patients from June 2012 to June 2014 were enrolled in this study. Fasting blood glucose and glycosylated hemoglobin (HbA1c) were tested in patients with diabetes mellitus. Results A total of 47 cases were detected in 350 patients with fasting blood glucose level ≥7.0 mmol / L, accounting for 13.43% of the total screening population. 44 cases were detected with glycated hemoglobin level≥6.5%, accounting for 12.57% of the total screening population. 68 cases were detected with fasting blood glucose≥7.0 mmol / L and glycosylated hemoglobin≥6.5%, accounting for 19.43% of the total screening population. There was no statistical difference between the single test results of fasting blood glucose and the single test results of glycosylated hemoglobin (P> 0.05). There was significant difference between the two test results (χ2 = 4.5886, 6.1225, P <0.05). Conclusion The screening of diabetes by fasting blood glucose combined with glycosylated hemoglobin test can effectively improve the screening rate of diabetic patients and provide a strong basis for the early diagnosis and treatment of diabetes, which is worth promoting.